top of page
Search Results

200 items found for "Transient receptor potential cation channel subfamily M member 8"

  • Ep 114 with Dr. Robert F. Bruns

    doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab. Bruns has over 80 publications and 11,000 citations, with an h-index of 47. Dr. Robert F.

  • Ep 90 with Dr. Nariman Balenga

    and received my Ph.D. in Molecular Medicine in 2010 after studying the orphan atypical cannabinoid receptor I studied the function of RGS5, calcium-sensing receptor, and an orphan adhesion GPCR, GPR64/ADGRG2 in with hyperparathyroidism and their impact on body calcium homeostasis and bone resorption in relevant transgenic

  • The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure

    G-protein-coupled receptors (GPCRs) are the most intensively studied drug targets but are underexplored We also developed transgenic mice expressing a chemogenetic CD8-restricted Gαs-DREADD to activate CD8 Saddawi-Konefka , Zhiyong Wang , Alexander T Wenzel , Miranda J Song , Meghana S Pagadala , Lauren M

  • Ep 39 with Dr. Kathryn E Livingston

    John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid receptors Research into their mechanism of action in purified systems formed the base of her thesis work. There she researched the beta-2 adrenergic receptor and developed assays to investigate real-time activity

  • Ep 151 with Dr GPCR Board

    GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors important discoveries related to the mechanisms that control PAR1 signaling and closely related family members Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

  • Ep 86 with Nicole (Nicki) Perry-Hauser

    endeavoring to build a productive, independent scientific research career in adhesion G protein-coupled receptor research interests involve resolving signaling pathways downstream of aGPCRs and establishing how/if these receptors

  • Ep 70 with Dr. Stephen Ferguson

    Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor

  • Ep 110 with Dr. G. Aditya Kumar

    at Hyderabad, India, where he studied the interaction of membrane cholesterol with the serotonin-1A receptor and its effects on receptor signaling and endocytosis. molecular pharmacology, subcellular trafficking, and membrane biology to better understand how the dynamic receptor

  • Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies

    cytoskeleton organization by the kinase effectors of Rho GTPases" and "Immune response B cell antigen receptor Our findings suggest that the GNAI3 gene holds potential as a prognostic biomarker for GBM. Kumar , Adrian Wangsawijaya Santoso , Bianca Tobias William , Chih-Yang Wang Tags G-protein-coupled receptor

  • Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil chemoattractant

    < GPCR News < GPCRs in Oncology and Immunology Chemokine Cxcl1-Cxcl2 heterodimer is a potent neutrophil Here, we characterized the role for heterodimer and show that the Cxcl1-Cxcl2 heterodimer is a potent Chemokine-mediated neutrophil recruitment is determined by Cxcr2 receptor signaling, Cxcr2 endocytosis These data collectively indicate that optimal glycosaminoglycan interactions and dampened receptor activity

  • Ep 89 with Dr. Patrick Sexton

    Patrick Sexton Patrick Sexton is a Professor of Pharmacology, National Health and Medical Research Council Researcher in two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification, and a member of the Faculty of 1000 (Molecular Pharmacology division) and an elected

  • Ep 148 with Dr Arthur Christopoulos

    He has served on the Editorial Board of 8 international journals and was a Councillor of the International hiring based on differentiation, impact, and interest, the need for workforce development, and the potential also shared their admiration for the work of a mutual friend and discussed the history of muscarinic receptors Lastly, they discussed the progress of new drugs targeting specific receptors for various diseases, with Arthur sharing insights on Eli Lilly's compound, Xanomeline, and the potential of M4 PAM for psychosis

  • Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer

    One approach to treating patients suffering from lung cancer is to target surface receptors overexpressed on tumor cells, such as GPCR-family kinin receptors, and proteases that control tumor progression, such Considering the multiple functions of kinin receptors and KLKs, this review highlights their roles, even Villarroel-Espindola , Carlos D Figueroa , Pamela Ehrenfeld Tags KLKs , Kallikrein-related peptidases , Kinin receptors

  • Ep 80 with Dr. Andrew Tobin

    consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation in the field of receptor Now at the University of Glasgow, his primary research interests are focused on the rational design of around 15 staff supported by basic research grants investigating aspects of disease biology and the action

  • Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    focused on investigating the cellular effects of missense lung cancer-mutations in the G-protein-coupled receptor Autoproteolysis-Inducing (GAIN) domain of Latrophilin 3 receptor under the mentorship of Dr.

  • GPR4 in the pH-dependent migration of melanoma cells in the tumor microenvironment

    in the tumor microenvironment Published date December 23, 2022 Abstract Due to its high metastatic potential Membrane-bound receptors, such as the proton-sensitive GPCR (pH-GPCR) GPR4, are considered as potential

  • GprC of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells for nematode hunting

    nematode-trapping fungus, Arthrobotrys flagrans, that both are achieved through a dual-function G-protein-coupled receptor This dual localization of GprC in A. flagrans resembles the localization of the cannabinoid receptor A. flagrans, and C. elegans SRBC64/66 and DAF38 share ascaroside-binding sites with the fungal GprC receptor

  • Ep 77 with Martin Audet

    Pharmacology of Sherbrooke and is an emerging leader in the structural biology of G Protein-Coupled Receptors Fellow at Scripps Research in San Diego and the University of Southern California in Los Angeles as a member

  • Ep 04 with Dr. Graciela Pineyro

    Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin receptors Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling

  • Ep 155 with Endocrine Metabolic GPCR Organizers

    Mark von Zastrow where she identified novel core cellular machinery critical for G protein-coupled receptor cell biological mechanisms regulating GPCR activity, including spatial control of GPCR signaling and receptor postdoctoral research in Oxford, investigating the signalling and trafficking of the G protein-coupled receptor (GPCR), calcium-sensing receptor, and its role in calcium homeostasis.

  • Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

    , single-center analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor The incidence of severe infections was higher with BsAb (40%) than CAR-T (26%) or ADC (8%), including Rose Tan, Malin Hultcrantz, Sergio A Giralt, Saad Z Usmani, Zainab Shahid, Sham Mailankody, Alexander M

  • Ep 49 with Dr. Sudha Shenoy

    Shenoy’s postdoctoral research discovered that ubiquitination of mammalian G protein-coupled receptors for lysosomal degradation, whereas ubiquitination of the adaptor protein, β-arrestin, is a tag for receptor

  • Ep 120 with Brendan Wilkins

    assistant at the Victor Chang Cardiac Research Institute where he investigated the orphan G protein-coupled receptor Brendan is now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor

  • Ep 20 with Dr. Jennifer Pluznick

    Pluznick discovered that olfactory receptors in mice are also expressed in their kidneys and blood vessels GPCRs in regulating renal and cardiovascular function, and identifying renal/cardiovascular olfactory receptor

  • Ep 19 with Dr. Fiona Marshall

    episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor biology, Fiona published the first description of the cloning and structural requirements of the GABAB receptor

  • About Us | Dr. GPCR Ecosystem

    GPCR Ecosystem We bring the GPCR community to fuel GPCR drug discovery one receptor at a time. GPCR Ecosystem, you’ll get to: Interact with the members and partners to help you find: Answers to any Join us today and you’ll get to: Interact directly with your target audience Access to all member perks

  • Newsletter Sign Up | Dr. GPCR Ecosystem

    which we've curated the major advances in understanding GPCR biology and moving closer to targeting receptors

  • Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone

    fibrosis in a murine model with fibrotic bone Published date May 1, 2024 Abstract "G protein-coupled receptors mice, in which Gs-GPCR signaling was hyper-activated in osteoblastic cell lineages using an engineered receptor fibrotic bone disease , fibrous dysplasia (FD) , osteoblasts , trabecular bone , G-protein coupled receptor

bottom of page